topic

1038 T cell factor 1 (TCF-1) is a molecular checkpoint in colorectal carcinoma γδ T cell immunity
Marina Yakou, Sonia Ghilas, Kelly Tran, Yang Liao, Shoukat Afshar-Sterle, Anita Kumari, Kevin Schmid, Christine Dijkstra, Chantelle Inguanti, Simone Ostrouska, Jordan Wilcox, Maxine Smith, Pavitha Parathan, Amr Allam, Hai-Hui Xue, Gabrielle Belz, Andreas Behren, John Mariadason, Grant Drummond, Roland Ruscher, David Williams, Bhupinder Pal, Wei Shi, Matthias Ernst, Dinesh Raghu, Lisa A Mielke

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1145; DOI: 10.1136/jitc-2023-SITC2023.1038
1039 A minimal gene set to overcome phenotypic heterogeneity in characterization of neoantigen-specific TIL in lung cancer
Zhen Zeng, Sydney Connor, Jiajia Zhang, Wentao Zhan, Hongkai Ji, Drew Pardoll, Kellie N Smith

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1146; DOI: 10.1136/jitc-2023-SITC2023.1039
1040 Immune profiling of aged mice bearing glioblastoma
Sarah Cook, Kelly Hotchkiss, Eliese Moelker, Eugene Cho, Aditya Mohan, John Sampson, Mustafa Khasraw

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1147; DOI: 10.1136/jitc-2023-SITC2023.1040
1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model
Avijit Goswami, Barnali Deb, Sandeep Goyal, Princy Khurana, Kawaljit Singh, Aditya Kulkarni

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1148; DOI: 10.1136/jitc-2023-SITC2023.1041
898 Demonstration of the utility of real-world progression-free survival (rwPFS) by application of an IFN-γ-related signature in a real-world cohort of patients with melanoma
Michael D Radmacher, Phaedra Agius, Oliver A Hampton, David M McKean, Daniel R Elgort, Robert J Rounbehler, Michelle Churchman, Donghai Dai, Tingyi Li, Abdul Rafeh Naqash, Margaret E Gatti-Mays, Aakrosh Ratan, Martin D McCarter, John Carpten, Howard Colman, Igor Puzanov, Susanne M Arnold, Issam El Naqa, Aik Choon Tan, Timothy I Shaw, Xuefeng Wang, William S Dalton, George J Weiner, Ahmad A Tarhini

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1000; DOI: 10.1136/jitc-2023-SITC2023.0898
899 emObject: domain specific data abstraction for spatial omics
Ethan Baker, Aaron Mayer, Alexandro E Trevino

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1001; DOI: 10.1136/jitc-2023-SITC2023.0899
900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy
Christian E Laing, Quanyuan He, Tony Collins, Meghan Verschoor, Chantal G Martin, Stewart E Abbot, Michael Ciancanelli

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1002; DOI: 10.1136/jitc-2023-SITC2023.0900
901 Abstract withdrawn
Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1003; DOI: 10.1136/jitc-2023-SITC2023.0901
902 A generative artificial intelligence engine for tertiary research and predictive modeling in immunotherapy
Sanat Mohanty, Vaijayanti Gupta, Omkar Patil, Abhishek Mamdapure

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1004; DOI: 10.1136/jitc-2023-SITC2023.0902
903 Identification of non-small cell lung cancer (NSCLC) patient subgroups with poor response to immunotherapy using subgroup-level meta-analyses
Kinisha Gala, Darko Medin, Ankit Kalucha, Judith Pérez Granado, Bruno Larvol, Mark Gramling

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1005; DOI: 10.1136/jitc-2023-SITC2023.0903

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages